Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema: A Post Hoc Analysis of the RIDE/RISE Trials (Q46081457)

19 December 2017

title

Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema: A Post Hoc Analysis of the RIDE/RISE Trials (English)

1 reference

19 December 2017

1 reference

diabetic macular edema

1 reference

1 reference

glycosylated hemoglobin

23 October 2023

Alok S Bansal

1

1 reference

19 December 2017

Rahul N Khurana

2

1 reference

19 December 2017

Mark R Wieland

3

1 reference

19 December 2017

Pin-Wen Wang

4

1 reference

19 December 2017

Sherri A Van Everen

5

1 reference

19 December 2017

Lisa Tuomi

6

1 reference

19 December 2017

publication date

4 June 2015

1 reference

19 December 2017

published in

Ophthalmology

1 reference

19 December 2017

volume

122

1 reference

19 December 2017

issue

8

1 reference

19 December 2017

page(s)

1573-1579

1 reference

19 December 2017

Persistent diabetic macular edema is associated with elevated hemoglobin A1c.

cites work

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c).

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Pretreatment clinical variables associated with the response to intravitreal bevacizumab (Avastin) injection in patients with persistent diabetic macular edema

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Global prevalence and major risk factors of diabetic retinopathy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Standards of medical care in diabetes--2014

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Prevalence of and risk factors for diabetic macular edema in the United States

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Long-term effects of ranibizumab on diabetic retinopathy severity and progression

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Relationship of diabetic macular oedema with glycosylated haemoglobin

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Glucose regulation influences treatment outcome in ranibizumab treatment for diabetic macular edema.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

The effect of glycemic control on visual and anatomic outcomes in response to therapy for diabetic macular edema

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.OPHTHA.2015.04.029

Identifiers

DOI

10.1016/J.OPHTHA.2015.04.029

1 reference

19 December 2017

1 reference

19 December 2017